These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5482214)

  • 1. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
    Topciu V; Moldovan E; Csaky N; Băcilă E
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of 3 measles vaccines. II. Evaluation of antibody levels and serologic conversion after vaccination according to the results of hemagglutination-inhibition test].
    Przegl Epidemiol; 1969; 23(2):175-83. PubMed ID: 5803031
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of hemagglutination inhibition tests for the determination of measles antibodies. I. Determination of measles antibodies in sera of children vaccinated against measles].
    Kolchurina AA; Semen'kova LI
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():266-72. PubMed ID: 5860947
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten".
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S
    Biken J; 1971 Mar; 14(1):77-9. PubMed ID: 5090682
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between haemagglutination inhibition test and enzyme immunoassay for evaluation of measles immune status and seroconversion to measles vaccine.
    Gebreselassie L; Melamed MD
    Ethiop Med J; 1983 Jul; 21(3):139-42. PubMed ID: 6349985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum titration of children vaccinated against measles].
    Morzycka M; Barteczkoi
    Pediatr Pol; 1968 Jul; 43(7):813-6. PubMed ID: 4174897
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.